Background

Tobacco smoke is a primary driver of direct genomic mutations due to its vast array of carcinogens. However, the precise molecular and cellular mechanisms explaining why some patients develop squamous cell carcinoma while others progress to adenocarcinoma or small cell lung cancer, despite similar exposure, have long remained unknown. Traditionally, it has been believed in the academic community that the accumulation of random mutations in cancer genes and the inherent cellular position determine the tumor type.

Existing studies focused on decoding the genomic sequences of already formed tumor tissues. This approach has the limitation of failing to capture how the intracellular environment is restructured during the early stages of carcinogenesis. It was difficult to track in real-time the epigenetic remodeling and disruption of differentiation pathways experienced by respiratory epithelial tissues undergoing chronic irritation before oncogenes are activated. There was an urgent need for a new approach to clearly elucidate the cellular lineage trajectories that various progenitor cells constituting the lung follow when exposed to external toxins.

Key Findings

This study, published in the October 2026 issue of the Proceedings of the National Academy of Sciences (PNAS), confirmed that chronic inflammation triggered by cigarette smoke directly drives the lineage evolution of lung progenitor cells. Researchers precisely tracked the process by which major progenitor populations within lung tissue, such as basal cells, club cells, and type 2 alveolar epithelial cells (AT2), rearrange their differentiation fates in response to long-term toxic stimuli.

Using a combination of single-cell RNA sequencing and lineage tracing models, the results showed that epithelial progenitor cells exposed to chronic inflammation deviated from the existing normal tissue differentiation pathways. Cell groups that entered an abnormal progenitor state showed a pattern of becoming selectively vulnerable to specific oncogenic mutations. For example, the basal progenitor cell population activated squamous cell carcinoma-specific transcription factor networks early under continuous inflammatory signals, subsequently developing addiction to subsequent genetic mutations.

Conversely, distal airway progenitors strongly coupled with adenocarcinoma-inducing pathways under inflammatory stress. In animal model experiments, the research team demonstrated that when inflammatory mediators are continuously secreted, susceptibility to carcinogenesis and final tumor morphology vary significantly depending on the state of the progenitor cells, even with the introduction of identical KRAS or EGFR mutations. The irreversible epigenetic state acquired by cells during chronic stimulation acted as a scaffold, inducing addiction to specific oncogenic signals. This proves that smoking goes beyond damaging DNA sequences; it pre-forms the histological substrate where oncogenes can take hold.

Significance and Outlook

This discovery expands the understanding of the pathogenesis of smoking-related lung cancer from a focus on genomic mutations to the interplay between cellular plasticity and the tissue microenvironment. It provides the insight that carcinogens do not merely induce specific mutations at random, but rather that chronic inflammatory signals first alter cell fate, creating fertile ground for mutations to take hold.

Clarifying this mechanism presents a significant turning point for cancer prevention and early interception treatment strategies. While it is nearly impossible to reverse already accumulated genetic mutations, there is sufficient room for pharmacological intervention in the inflammatory signal transduction pathways of progenitor cells entering abnormal differentiation trajectories. The potential to use changes in the progenitor state of airway epithelial cells as an indicator for screening high-risk lung cancer groups, beyond simple smoking history or the presence of specific genetic mutations, has emerged.

However, follow-up research must address how long progenitor cells altered by chronic inflammation remain in a latent state in actual human tissues and whether they are reversible to return to a normal trajectory after smoking cessation. Rigorous verification is required to ensure that the cellular trajectories observed in experimental models are reproducible in actual patient cohorts with diverse genetic backgrounds.